Author: Ravi Shankar

Haverford, PA, Nov. 13, 2026 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU) (the “Company”) today reported financial results for the third quarter ended September 30, 2026, and provided an update on operating activity during the quarter. The quarter reflected a continued contraction in the Company’s marketing network, a 10% increase in revenue from its health, beauty, and wellness businesses versus the second quarter of 2026, and continued investment in pre-commercial operations. Net income for the quarter was $9.0 million versus a $3.2 million loss in the second quarter of 2026, primarily attributable to the sale of the Company’s equity investment in an early-stage nuclear power and infrastructure technology company. The sale generated $10.8 million in net cash proceeds, strengthening the Company’s financial position while its operating businesses continued to face challenges. Management will continue to focus on simplifying the portfolio, strengthening capital-allocation discipline, and clarifying the roles of its operating businesses, including selective commercial integration among Conectiv, MyLife Wellness, and Renu Laboratories.

Summary Consolidated Financial Highlights

Results of Operations — Three Months Ended September 30, 2026 vs. September 30, 2025

• Gross Revenue (a Non-GAAP measure) decreased 72.6% to $2.4 million for the three months ended September 30, 2026, compared to $8.6 million for the comparable prior-year period.
• Net Revenue decreased 72.5% to $2.2 million for the three months ended September 30, 2026, compared to $8.1 million for the comparable prior-year period.
• Net cash used in operating activities was $1.5 million for the three months ended September 30, 2026, compared to net cash provided by operating activities of $0.6 million for the comparable prior-year period.
• Loss from Operations (excluding discontinued operations) was $2.1 million for the three months ended September 30, 2026, compared to $0.7 million for the comparable prior-year period.
• Net Income increased $9.8 million to $9.0 million for the three months ended September 30, 2026, compared to a $0.8 million Net Loss for the comparable prior-year period. The increase was mainly due to the sale of the Company’s equity investments in an early-stage company focused on developing next-generation nuclear power and infrastructure technology.

Results of Operations — Nine Months Ended September 30, 2026 vs. September 30, 2025

• Gross Revenue (a Non-GAAP measure) decreased 70.0% to $8.4 million for the nine months ended September 30, 2026, compared to $28.0 million for the comparable prior-year period.
• Net Revenue decreased 69.6% to $8.1 million for the nine months ended September 30, 2026, compared to $26.5 million for the comparable prior-year period.
• Net cash used in operating activities was $7.1 million for the nine months ended September 30, 2026, compared to net cash used in operating activities of $3.1 million for the comparable prior-year period.
• Loss from Operations (excluding discontinued operations) was $6.4 million for the nine months ended September 30, 2026, compared to $38.3 thousand for the comparable prior-year period.
• Net Income increased $3.0 million to $1.9 million for the nine months ended September 30, 2026, compared to a $1.1 million Net Loss for the comparable prior-year period. The increase was mainly due to the sale of the Company’s equity investments in an early-stage company focused on developing next-generation nuclear power and infrastructure technology.

Balance Sheet Data — September 30, 2026 vs. December 31, 2025

• Cash, cash equivalents and digital assets increased 20.4% to $18.6 million at September 30, 2026, an increase of $3.2 million from $15.5 million at December 31, 2025. The increase was primarily attributable to $10.8 million in net cash proceeds from the sale of the Company’s equity investment in an early-stage company developing next-generation nuclear power and infrastructure technology, partially offset by $7.1 million in net cash used in operating activities.
• Total assets increased $0.5 million, or 2.5%, to $22.0 million. Total liabilities decreased $0.9 million, or 7.2%, to $11.7 million. The Company’s current ratio increased 33% to 2.83 as of September 30, 2026.
• Working capital increased $2.7 million, or 39.4%, as of September 30, 2026, compared to December 31, 2025, excluding $5.7 million in liquid digital assets held at quarter-end.
• Outstanding debt increased by $0.3 million to $3.9 million at September 30, 2026, up from $3.6 million at December 31, 2025.
• Total stockholders’ equity was $10.4 million at September 30, 2026, an increase of $1.5 million, or 16.3%, from $8.9 million at December 31, 2025. During the third quarter, the Company repurchased 1,958,841 shares of its common stock under its authorized stock repurchase program at an average price of $0.0182 per share, representing a 0.11% reduction in common shares outstanding. For the nine months ended September 30, 2026, the Company repurchased a total of 4,821,883 shares at an average price of $0.0219 per share, representing a cumulative 0.26% reduction in common shares outstanding.

Portfolio Company and Strategic Review

Direct-to-Consumer Marketing Platform — Conectiv

Conectiv net revenue was $1.8 million in the third quarter of 2026, a decrease of $5.2 million, or 74.1%, compared to the prior-year period. The decline primarily reflected continued contraction in the Company’s European marketing network following the December 2025 UOKiK administrative decision in Poland. The Company has appealed the decision, which remains pending, and continues to operate in European Union markets under its applicable compliance procedures.

During 2026, Conectiv continued its strategic transition from a financial education-focused platform to an integrated Finance + Wellness + Lifestyle membership offering. The expanded model combines financial education and tools with MyLife Wellness products, travel and lifestyle benefits, live events, and community engagement, supported by subscription-based memberships and recurring product replenishment programs. In this model, Conectiv provides the membership and distributor infrastructure, MyLife Wellness markets consumer health and wellness products, and Renu Laboratories provides product development and manufacturing capabilities.

During the third quarter, Conectiv introduced Coneqtx, a new mobile trading education application providing access to an expanded library of financial education content, trading tools, market research, and analysis. The application is intended to enhance the member experience and support engagement and retention.

Conectiv also expanded its distribution network through the addition of two selling organizations during 2026 and continued advancing its omnichannel sales and marketing strategy, integrating independent distributors with direct-to-consumer digital marketing, social media, influencer partnerships, and live events to broaden customer reach and support membership growth.

Although management expects that in the long-term the operational initiatives it has implemented during 2026 will improve Connectiv’s results of operation, to date, these initiatives have not yet produced an increase in sales sufficient to offset the decline in Connectiv’s European and other operations. Despite these headwinds, management remains focused, however, on strengthening member engagement and retention, developing additional recurring revenue streams, and improving operating performance through its expanded membership offerings and integrated sales and marketing initiatives.

Health, Beauty, and Wellness Products

The Health, Beauty, and Wellness Products segment, which entails the financial results of Renu Laboratories and MyLife Wellness, generated net revenue of $0.4 million for the three months ended September 30, 2026, compared to $1.1 million for the same period in 2025 — a decrease of $0.6 million, or 59.3%.

Renu Laboratories

Renu Laboratories, the Company’s U.S.-based, FDA-registered contract manufacturer of skincare, haircare, body care, and wellness products, continued to implement a strategic shift toward higher-margin customer relationships and more profitable manufacturing opportunities. As part of this transition, management discontinued or restructured certain higher-volume, lower-margin customer arrangements, contributing to lower revenue during the quarter while positioning the business to pursue opportunities with more favorable margin characteristics.

The Company continues to pursue new customer opportunities and expanded relationships with existing customers. It is also pursuing targeted investments in business development, marketing, manufacturing capabilities, production technology, and key personnel, while evaluating potential strategic business combinations to support customer acquisition, production efficiency, and longer-term growth. Despite the continued contraction in the Renu business, management remains focused on rebuilding manufacturing volume and strengthening operating performance, while evaluating the business based on revenue performance, customer profitability, operating costs, and capital requirements.

MyLife Wellness  

MyLife Wellness (“MLW”), the Company’s consumer health and wellness brand, leverages Renu Laboratories’ product development and manufacturing capabilities alongside Conectiv’s technology, membership, and distributor infrastructure. Its product portfolio includes supplements supporting gut, metabolic, cognitive, and sleep health, functional coffee, pain relief and recovery products, and facial-care offerings, distributed through e-commerce and the Company’s distributor network.

The Company continues to strengthen its direct-to-consumer marketing initiatives, digital and social media presence, influencer partnerships, and distributor engagement to broaden brand awareness and customer reach. Management remains focused on expanding recurring product sales and repeat customer purchasing through its product portfolio and distribution channels.

Financial Services Initiatives

Opencash Securities — Development and Commercialization Update

During the third quarter of 2026, the Company continued to advance the development and commercialization efforts of Opencash Securities LLC (“Opencash”), its registered broker-dealer and digital brokerage platform.

Although not yet ready for commercial application, the platform is being developed to support trading in equities, exchange-traded funds (“ETFs”), equity options, and mutual funds. The Company intends to introduce two complementary offerings for self-directed retail investors: Opencash, a mobile application designed for emerging and experienced investors seeking accessible and intuitive trading capabilities, and OpencashPro, a web-based platform tailored to active and more experienced traders seeking advanced market data, analytical tools, and expanded trading functionality.

The Company is targeting initial commercial operations by the end of the second quarter of 2027, with a phased expansion of platform capabilities and services anticipated through the remainder of 2027 and into 2028. Launch timing and platform capabilities remain subject to applicable regulatory requirements, third-party capabilities, and operational and technological readiness; no definitive launch date has been established. As of September 30, 2026, Opencash remained pre-commercial and pre-revenue, with the Company continuing to incur related development and operating expenses.

Management Commentary

Victor Oviedo, Chief Executive Officer of Investview, stated:

“Our third-quarter results reflect both the challenges of an ongoing business transition and the progress we are making in strengthening our financial position. Although during the quarter our net revenue declined to $2.2 million, and we reported an operating loss (excluding discontinued operations) of $2.1 million, and net income of $9.0 million, we also significantly enhanced our liquidity as we sold for $10.8 million our equity investment in an early-stage nuclear power and infrastructure technology company. While the resulting gain was non-operating, the additional liquidity gives us greater flexibility as we address operating performance. We ended the quarter with $18.6 million in cash, cash equivalents, and digital assets and a current ratio of 2.83, and we continued repurchasing shares under our authorized program.”

“We are mindful of our continued losses from operations, and we remain laser focused on rationalizing our business portfolio, allocating capital with discipline, and managing costs carefully. We need to continue to execute on the strategic initiatives adopted by the Company intended to strengthen member engagement and retention at Conectiv, expand product sales at MyLife Wellness, rebuild profitable manufacturing volume at Renu Laboratories, and advance Opencash toward commercial launch. We will evaluate each business based on its operating performance, profitability, cash flow, and capital requirements, with the objective of strengthening our financial foundation and creating long-term shareholder value.”  

About Investview, Inc.

Investview, Inc., a Nevada corporation, operates a diversified series of marketing, manufacturing,   and distribution business units that offer goods, products, and services across multiple sectors, including financial education and lifestyle, consumer wellness, contract manufacturing and brokerage technology, as well as a development-stage online trading platform that intends to offer self-directed retail brokerage services. For more information, please visit www.investview.com.

About Opencash Securities LLC

Brokerage services are provided by Opencash Securities LLC, a member of FINRA and SIPC. Options trading involves risk and is not suitable for all investors. Please review the Characteristics and Risks of Standardized Options before engaging in options trading. Opencash Securities LLC does not provide investment advice. Investors should consult with qualified investment, tax, or legal professionals before making investment decisions. All investments involve risk, including the possible loss of principal.

Check the background of Opencash Securities LLC on FINRA’s BrokerCheck at brokercheck.finra.org. Opencash Securities LLC is registered as a broker-dealer in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.

Opencash Securities LLC is a wholly owned subsidiary of Investview, Inc.

Forward-Looking Statement

All statements in this release that are not based on historical fact are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies, and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. These forward-looking statements are based on management’s current beliefs and assumptions and information currently available to management and involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. Our forward-looking statements expect that we will be able to expand the scope and scale of our Conectiv network, despite the reductions in revenue experienced by this business segment during 2025 and followed by the more significant contraction in the business that occurred during the first three quarters of 2026. These expectations assume that our recent onboarding of certain other direct selling networks will result in material additional sales growth, even though no such sales growth can be assured as these other direct selling networks that we onboarded consist solely of independent distributors who are not contractually or otherwise required to sell any Conectiv products or services. Growth is also expected from our Manufacturing and Development of Health, Beauty and Wellness Products Segment, as we continue to seek out and onboard additional products for sale, even though we have over time experienced reduction in sales of that business unit and have no customer or other sales commitments upon which to base that expectation. Our forward-looking statements also expect that we will ultimately be able to develop retail brokerage operations at Opencash, although it is currently in the pre-revenue and early stage of its operations. We plan to do this by, among others, investing the funds we believe are necessary to develop the infrastructure necessary to achieve retail operations. This includes, among others, the onboarding of customer support personnel and software developers, the development and implementation of a marketing strategy, the securing of necessary securities clearing arrangements, and the continued development of the online Opencash trading platform and completing its integration with the proprietary algorithmic trading platform we acquired in September 2021. Despite our best efforts, there can be no assurance that we will be able to achieve these objectives on a timely basis, if at all, as the development of an early-stage securities brokerage business involves inherent regulatory and operational risks and uncertainties, including the uncertain ability of us to integrate the Opencash investment platform application with the proprietary algorithmic trading platform we acquired in September 2021, particularly as the platform we acquired in 2021 has not been placed in commercial service since 2021; thus, any such integration could be subject to IT-related and commercial risks. Furthermore, all of our forward-looking statements presume that we will be able to continue to operate as a going concern in the long-term. As noted in our Quarterly Report on Form 10-Q for the period ended September 30, 2026, should our strategic initiatives fail to mitigate our losses from operations or otherwise achieve their targeted objectives, then in the absence of our ability to access additional debt or equity capital, our ability to sustain our operations in the long-term as a going concern may be subject to doubt. More information on potential factors that could affect our financial results is included from time to time in our public reports filed with the U.S. Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. The forward-looking statements made in this release speak only as of the date of this release, and we assume no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.

Investor Relations
Contact: Ralph R. Valvano
Phone Number: 732.889.4300
Email: pr@investview.com

Reconciliation of Gross Revenue to Net Revenue
(unaudited)

As used in this report, Gross Revenue is not a measure of financial performance under United States Generally Accepted Accounting Principles (“GAAP”). Gross Revenue is presented as it is used by management to understand total revenue before certain items such as refunds, incentives, credits, chargebacks, and amounts paid to third-party providers. This non-GAAP measure supplements the Company’s GAAP financial information. A reconciliation between Gross Revenue (non-GAAP) and Net Revenue is presented below.

Nine Months Ended September 30, 2026

		Membership revenue				Health and wellness product sales				Coffee Sales				Other Revenue				Total
Gross billings/receipts		$	6,970,999			$	751,409			$	661,489			$	15,263			$	8,399,160
Refunds, incentives, credits, and chargebacks			(311,116	)			(1,713	)			(31,348	)			–				(344,177	)
Net revenue		$	6,659,883			$	749,696			$	630,141			$	15,263			$	8,054,983

Nine Months Ended September 30, 2025

		Membership revenue				Health and wellness product sales				Other Revenue				Total
Gross billings/receipts		$	25,166,094			$	2,722,041			$	78,249			$	27,966,384
Refunds, incentives, credits, and chargebacks			(1,463,235	)			(12,349	)			–				(1,475,584	)
Net revenue		$	23,702,859			$	2,709,692			$	78,249			$	26,490,800

Three Months Ended September 30, 2026

		Membership revenue				Health and wellness product sales				Coffee Sales				Other Revenue				Total
Gross billings/receipts		$	1,933,562			$	238,372			$	178,678			$	3,084			$	2,353,696
Refunds, incentives, credits, and chargebacks			(114,074	)			–				(1,042	)			–				(115,116	)
Net revenue		$	1,819,488			$	238,372			$	177,636			$	3,084			$	2,238,580

Three Months Ended September 30, 2025

		Membership revenue				Health and wellness product sales				Other Revenue				Total
Gross billings/receipts		$	7,526,954			$	1,041,851			$	32,598			$	8,601,403
Refunds, incentives, credits, and chargebacks			(460,220	)			(12,178	)			–				(472,398	)
Net revenue		$	7,066,734			$	1,029,673			$	32,598			$	8,129,005

MUNCIE, Ind., Nov. 13, 2026 (GLOBE NEWSWIRE) — First Merchants Corporation declared a cash dividend on November 13, 2026 of $0.37 per common share. The dividend is payable on December 18, 2026 to common shareholders of record as of December 4, 2026.

About First Merchants Corporation:

First Merchants Corporation is a financial holding company headquartered in Muncie, Indiana. The Corporation has one full-service bank charter, First Merchants Bank. The Bank also operates as First Merchants Private Wealth Advisors (as a division of First Merchants Bank).

First Merchants Corporation’s common stock is traded on the NASDAQ Global Select Market under the symbol FRME. Quotations are carried in daily newspapers and can be found on the company’s Internet web page (http://www.firstmerchants.com).

FIRST MERCHANTS and the Shield Logo are federally registered trademarks of First Merchants Corporation.

For more information, contact:
Nicole M. Weaver, Senior Vice President and Director of Corporate Administration
765-521-7619
http://www.firstmerchants.com

Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme

Attachment

• 20261113 SBB EN

Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme

Attachment

• 20261113 SBB EN

CALGARY, Alberta, Nov. 13, 2026 (GLOBE NEWSWIRE) — Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Corporation”) is pleased to announce that independent proxy advisory firms, including Institutional Shareholder Services (“ISS”), have recommended shareholders vote “FOR” the proposed plan of arrangement (the “Arrangement” or the “Transaction”) with Cenovus Energy Inc. (“Cenovus”).

• The Board of Directors of Athabasca (the “Athabasca Board”) unanimously recommends that shareholders vote FOR the Transaction.
• Shareholders are reminded to vote and make their election choice well in advance of the November 25, 2026 proxy voting and election deadlines.
• Questions or Require Voting Assistance? Contact Athabasca’s proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1‑877‑452‑7184 (toll-free in North America), 1-416-304-0211 (outside North America), by texting “INFO” to either number, or by email to assistance@laurelhill.com. Visit www.atha.com/2026-special-meeting for more information.

Independent Third-Party Proxy Advisory Recommendations

ISS is an independent proxy advisory firm whose clients include some of the world’s leading institutional investors, among others, who rely on its objective and impartial analysis to help inform their voting decisions.

ISS stated that “The transaction makes strategic sense due to the certainty of value and immediate liquidity provided by the premium cash consideration, while the CVE share consideration also provides an opportunity for additional upside through ownership in the combined company.”

Athabasca Board Recommendation

ISS’ recommendation to vote “FOR” the Arrangement is consistent with the unanimous recommendation of the board of directors of Athabasca. The Athabasca Board unanimously recommends that Athabasca Shareholders vote FOR the Transaction Resolution.

Vote Your Shares and Make Your Election Choice Today – Voting is Easy

The proxy voting deadline for shareholders is Wednesday, November 25, 2026 at 10:00 a.m. (Calgary time). Shareholders are encouraged to vote well in advance of the proxy voting deadline to ensure their vote is submitted in a timely manner. Athabasca shareholders may vote online, by telephone or any other methods provided in the form of proxy or voting instruction form included as part of the mailing of the management information circular.

How to Make a Consideration Election

Athabasca Shareholders have the option to elect to receive either the Cash Consideration, the Share Consideration or a combination of both. The Election Deadline for Athabasca Shareholders to make the consideration election is on November 25, 2026 at 4:30 p.m. (Calgary Time). Shareholders who do not make an election will be deemed to have elected to receive the Cash Consideration for their Athabasca Shares, subject to rounding and proration as set out in the Plan of Arrangement.

• For Beneficial Shareholders. If you hold common shares of Athabasca (“Athabasca Shares”) through a broker or other financial intermediary, contact your broker/intermediary to provide your election instructions. Your broker/intermediary may establish earlier deadlines for making elections. Beneficial Shareholders are encouraged to contact their intermediary/broker as soon as possible.
• For Registered Shareholders. If you hold Athabasca Shares directly in your name and represented by a share certificate or a DRS Advice, please complete the Letter of Transmittal and Election Form and return it along with any certificate(s) representing the Athabasca Shares held to Computershare, Athabasca’s Depositary. If your Athabasca Shares are represented by a DRS Advice, there is no requirement to submit the DRS Advice and only the completed Letter of Transmittal and Election Form is required.

The special meeting of Athabasca shareholders will be held on November 27, 2026, at 10:00 a.m. (Calgary time) in a hybrid format, allowing shareholders to attend in person or participate virtually. Meeting participation details, the management information circular and related meeting materials are available at www.atha.com/2026-special-meeting. Shareholders requiring assistance may contact Laurel Hill using the information provided below.

Shareholder Questions and Voting Assistance

If you have questions, including the procedures for voting, please contact Athabasca’s proxy solicitation agent:

Laurel Hill Advisory Group
Toll-free calls in North America at 1-877-452-7184 (1-416-304-0211 outside North America)
Text message by texting “INFO” to 416-304-0211 or 1-877-452-7184
Email at assistance@laurelhill.com

About Athabasca Oil Corporation
Athabasca Oil Corporation is a Canadian energy company with a focused strategy on the development of thermal and light oil assets. Situated in Alberta’s Western Canadian Sedimentary Basin, the Company has amassed a significant land base of extensive, high quality resources. Athabasca’s light oil assets are held in a private subsidiary (Duvernay Energy Corporation) in which Athabasca owns a 70% equity interest. Athabasca’s common shares trade on the TSX under the symbol “ATH”. For more information, visit www.atha.com.

For more information, please contact:
Matthew Taylor	Robert Broen
Chief Financial Officer	President and CEO
1-403-817-9104	1-403-817-9190
mtaylor@atha.com	rbroen@atha.com

Reader Advisory:
This News Release contains forward-looking information that involves various risks, uncertainties and other factors. All information other than statements of historical fact is forward-looking information. The use of any of the words “anticipate”, “plan”, “project”, “continue”, “maintain”, “may”, “estimate”, “expect”, “will”, “target”, “forecast”, “could”, “intend”, “potential”, “guidance”, “outlook” and similar expressions suggesting future outcome is intended to identify forward-looking information. The forward-looking information is not historical fact, but rather is based on the Company’s current plans, objectives, goals, strategies, estimates, assumptions and projections about the Company’s industry, business and future operating and financial results. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. No assurance can be given that these expectations will prove to be correct and such forward-looking information included in this News Release should not be unduly relied upon. This information speaks only as of the date of this News Release. In particular, this News Release contains forward-looking information pertaining to, but not limited to, the following: the anticipated benefits of the Transaction to Athabasca shareholders, including but not limited to near-term liquidity and value certainty and participation in future upside of Cenovus; the form of consideration and elections under the Transaction; the anticipated timing for holding of the shareholder meeting and the related voting and election deadlines; and other similar statements.

With respect to forward-looking information contained in this News Release, assumptions have been made regarding, among other things: the timely completion of the Transaction and the satisfaction of the conditions to which the Transaction is subject; the approval of the Transaction at the shareholder meeting; the shareholder meeting being held as scheduled; regulatory and government approvals for the Transaction, including approval of the Court of King’s Bench of Alberta and receipt of applicable regulatory and stock exchange approvals, in each case on the anticipated timelines; the realization of anticipated benefits of the Transaction; commodity prices.

Actual results could differ materially from those anticipated in this forward-looking information as a result of the risk factors set forth in the Company’s management information circular dated October 27, 2026 and Annual Information Form (“AIF”) dated March 4, 2026 available on SEDAR+ at www.sedarplus.ca, including, but not limited to: weakness in the oil and gas industry; prices, markets and marketing; market conditions; regulatory environment and changes in applicable law; postponement of the shareholder meeting; fluctuations in the value of Cenovus shares; the risk that required approvals are not obtained or other conditions to completion of the Transaction are not satisfied or waived; the risk that the Transaction is delayed, amended or terminated; and the risk that the anticipated benefits of the Transaction are not realized. All subsequent forward-looking information, whether written or oral, attributable to the Company or persons acting on its behalf is expressly qualified in their entirety by these cautionary statements. Further information regarding the assumptions and risks inherent in the making of forward-looking statements and in respect of the Transaction can be found in the management information circular, along with Athabasca’s other public disclosure documents, including the Company’s AIF dated March 4, 2026, which are available on SEDAR+ at www.sedarplus.ca.

The forward-looking information contained in this News Release was made as of the date of this News Release and the Company disclaims any intention or obligations to update or revise such forward-looking information, whether as a result of new information, future events or otherwise, unless required pursuant to applicable law.

CALGARY, Alberta, Nov. 13, 2026 (GLOBE NEWSWIRE) — Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Corporation”) is pleased to announce that independent proxy advisory firms, including Institutional Shareholder Services (“ISS”), have recommended shareholders vote “FOR” the proposed plan of arrangement (the “Arrangement” or the “Transaction”) with Cenovus Energy Inc. (“Cenovus”).

• The Board of Directors of Athabasca (the “Athabasca Board”) unanimously recommends that shareholders vote FOR the Transaction.
• Shareholders are reminded to vote and make their election choice well in advance of the November 25, 2026 proxy voting and election deadlines.
• Questions or Require Voting Assistance? Contact Athabasca’s proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1‑877‑452‑7184 (toll-free in North America), 1-416-304-0211 (outside North America), by texting “INFO” to either number, or by email to assistance@laurelhill.com. Visit www.atha.com/2026-special-meeting for more information.

Independent Third-Party Proxy Advisory Recommendations

ISS is an independent proxy advisory firm whose clients include some of the world’s leading institutional investors, among others, who rely on its objective and impartial analysis to help inform their voting decisions.

ISS stated that “The transaction makes strategic sense due to the certainty of value and immediate liquidity provided by the premium cash consideration, while the CVE share consideration also provides an opportunity for additional upside through ownership in the combined company.”

Athabasca Board Recommendation

ISS’ recommendation to vote “FOR” the Arrangement is consistent with the unanimous recommendation of the board of directors of Athabasca. The Athabasca Board unanimously recommends that Athabasca Shareholders vote FOR the Transaction Resolution.

Vote Your Shares and Make Your Election Choice Today – Voting is Easy

The proxy voting deadline for shareholders is Wednesday, November 25, 2026 at 10:00 a.m. (Calgary time). Shareholders are encouraged to vote well in advance of the proxy voting deadline to ensure their vote is submitted in a timely manner. Athabasca shareholders may vote online, by telephone or any other methods provided in the form of proxy or voting instruction form included as part of the mailing of the management information circular.

How to Make a Consideration Election

Athabasca Shareholders have the option to elect to receive either the Cash Consideration, the Share Consideration or a combination of both. The Election Deadline for Athabasca Shareholders to make the consideration election is on November 25, 2026 at 4:30 p.m. (Calgary Time). Shareholders who do not make an election will be deemed to have elected to receive the Cash Consideration for their Athabasca Shares, subject to rounding and proration as set out in the Plan of Arrangement.

• For Beneficial Shareholders. If you hold common shares of Athabasca (“Athabasca Shares”) through a broker or other financial intermediary, contact your broker/intermediary to provide your election instructions. Your broker/intermediary may establish earlier deadlines for making elections. Beneficial Shareholders are encouraged to contact their intermediary/broker as soon as possible.
• For Registered Shareholders. If you hold Athabasca Shares directly in your name and represented by a share certificate or a DRS Advice, please complete the Letter of Transmittal and Election Form and return it along with any certificate(s) representing the Athabasca Shares held to Computershare, Athabasca’s Depositary. If your Athabasca Shares are represented by a DRS Advice, there is no requirement to submit the DRS Advice and only the completed Letter of Transmittal and Election Form is required.

The special meeting of Athabasca shareholders will be held on November 27, 2026, at 10:00 a.m. (Calgary time) in a hybrid format, allowing shareholders to attend in person or participate virtually. Meeting participation details, the management information circular and related meeting materials are available at www.atha.com/2026-special-meeting. Shareholders requiring assistance may contact Laurel Hill using the information provided below.

Shareholder Questions and Voting Assistance

If you have questions, including the procedures for voting, please contact Athabasca’s proxy solicitation agent:

Laurel Hill Advisory Group
Toll-free calls in North America at 1-877-452-7184 (1-416-304-0211 outside North America)
Text message by texting “INFO” to 416-304-0211 or 1-877-452-7184
Email at assistance@laurelhill.com

About Athabasca Oil Corporation
Athabasca Oil Corporation is a Canadian energy company with a focused strategy on the development of thermal and light oil assets. Situated in Alberta’s Western Canadian Sedimentary Basin, the Company has amassed a significant land base of extensive, high quality resources. Athabasca’s light oil assets are held in a private subsidiary (Duvernay Energy Corporation) in which Athabasca owns a 70% equity interest. Athabasca’s common shares trade on the TSX under the symbol “ATH”. For more information, visit www.atha.com.

For more information, please contact:
Matthew Taylor	Robert Broen
Chief Financial Officer	President and CEO
1-403-817-9104	1-403-817-9190
mtaylor@atha.com	rbroen@atha.com

Reader Advisory:
This News Release contains forward-looking information that involves various risks, uncertainties and other factors. All information other than statements of historical fact is forward-looking information. The use of any of the words “anticipate”, “plan”, “project”, “continue”, “maintain”, “may”, “estimate”, “expect”, “will”, “target”, “forecast”, “could”, “intend”, “potential”, “guidance”, “outlook” and similar expressions suggesting future outcome is intended to identify forward-looking information. The forward-looking information is not historical fact, but rather is based on the Company’s current plans, objectives, goals, strategies, estimates, assumptions and projections about the Company’s industry, business and future operating and financial results. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. No assurance can be given that these expectations will prove to be correct and such forward-looking information included in this News Release should not be unduly relied upon. This information speaks only as of the date of this News Release. In particular, this News Release contains forward-looking information pertaining to, but not limited to, the following: the anticipated benefits of the Transaction to Athabasca shareholders, including but not limited to near-term liquidity and value certainty and participation in future upside of Cenovus; the form of consideration and elections under the Transaction; the anticipated timing for holding of the shareholder meeting and the related voting and election deadlines; and other similar statements.

With respect to forward-looking information contained in this News Release, assumptions have been made regarding, among other things: the timely completion of the Transaction and the satisfaction of the conditions to which the Transaction is subject; the approval of the Transaction at the shareholder meeting; the shareholder meeting being held as scheduled; regulatory and government approvals for the Transaction, including approval of the Court of King’s Bench of Alberta and receipt of applicable regulatory and stock exchange approvals, in each case on the anticipated timelines; the realization of anticipated benefits of the Transaction; commodity prices.

Actual results could differ materially from those anticipated in this forward-looking information as a result of the risk factors set forth in the Company’s management information circular dated October 27, 2026 and Annual Information Form (“AIF”) dated March 4, 2026 available on SEDAR+ at www.sedarplus.ca, including, but not limited to: weakness in the oil and gas industry; prices, markets and marketing; market conditions; regulatory environment and changes in applicable law; postponement of the shareholder meeting; fluctuations in the value of Cenovus shares; the risk that required approvals are not obtained or other conditions to completion of the Transaction are not satisfied or waived; the risk that the Transaction is delayed, amended or terminated; and the risk that the anticipated benefits of the Transaction are not realized. All subsequent forward-looking information, whether written or oral, attributable to the Company or persons acting on its behalf is expressly qualified in their entirety by these cautionary statements. Further information regarding the assumptions and risks inherent in the making of forward-looking statements and in respect of the Transaction can be found in the management information circular, along with Athabasca’s other public disclosure documents, including the Company’s AIF dated March 4, 2026, which are available on SEDAR+ at www.sedarplus.ca.

The forward-looking information contained in this News Release was made as of the date of this News Release and the Company disclaims any intention or obligations to update or revise such forward-looking information, whether as a result of new information, future events or otherwise, unless required pursuant to applicable law.

This press release corrects the “Percent Change (At Midpoint)” in the outlook table contained in the Company’s press release originally issued on November 12, 2026.  The corrected table is included herein.  There were no changes to the outlook ranges. In all other respects, the press release remains unchanged.

MINNEAPOLIS, Nov. 13, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its third quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited, in millions, except per share data, and Doctor counts)
	Three Months Ended September 30,													Nine Months Ended September 30,
	2026			2025							Change			2026					2025				Change
Revenue	$64.9			$61.3							6.0	%		$193.8					$183.3				5.8	%
Gross Margin	$8.2			$9.4							(13.3	%)		$24.1					$31.2				(22.8	%)
Gross Margin percentage	12.6	%		15.4					%		(280 bps)			12.4			%		17.0		%		(460 bps)
Net Income	$1.7			$1.3							36.1	%		$2.7					$5.4				(50.6	%)
Diluted EPS	$0.27			$0.72							($0.45	)		$0.43					$3.06				($2.63	)
Adjusted Gross Margin(a)	$12.1			$11.9							1.6	%		$39.0					$37.9				2.9	%
Adjusted Gross Margin Percentage(a)	18.6	%		19.4					%		(80 bps)			20.1			%		20.7		%		(60 bps)
Adjusted EBITDA(b)	$5.0			$5.3							(6.2	%)		$17.1					$18.3				(6.5	%)
Adjusted EBITDA margin(b)	7.7	%		8.7					%		(100 bps)			8.8			%		10.0		%		(120 bps)
Adjusted Diluted EPS(c)	$0.57			$ 1.19							($0.62	)		$1.68					$4.21				($2.53	)
Same Practice Revenue Growth	3.2	%		9.9					%		(670 bps	)		3.0			%		5.8		%		(280 bps)
Practicing Affiliated Doctors	225			218							3.2	%

^{(a) See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below
(b) See Non GAAP Reconciliation of Net Income to Adjusted EBITDA below
(c) See Non GAAP Reconciliation of Earnings Per Share to Adjusted Earnings Per Share below}

Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors

“Third-quarter revenue increased 6%, supported by same-practice growth, an expanding affiliated doctor base and contributions from recently acquired practices. We have made meaningful progress adding clinical capacity and strengthening our platform, and our focus now is converting that capacity and revenue growth into improved productivity and stronger earnings performance.

The completion of the Village Family transaction represents an important step in our growth strategy and extends our affiliated practice network into a fourth state. We remain focused on disciplined integration, supporting our affiliated practices and executing against the opportunities already within our business.”

Financial Results

• Revenue increased 6.0% to $64.9 million for the third quarter of 2026, compared to $61.3 million in the prior-year period. For the first nine months of 2026, revenue increased 5.8% to $193.8 million, compared to $183.3 million in the prior-year period. The increases were primarily driven by reimbursement trends, acquisitions completed since the comparable prior-year periods, and growth in clinical hours. Revenue from acquisitions in the past 12 months contributed approximately $1.2 million in the quarter and $3.7 million year-to-date.
• Gross margin was $8.2 million for the third quarter of 2026, compared to $9.4 million in the prior-year period. For the first nine months of 2026, gross profit was $24.1 million, compared to $31.2 million in the prior-year period. Gross profit was impacted by higher salaries and benefits expense, including doctor share-based compensation associated with the Company’s public company transition.
• Net income was $1.7 million, or $0.27 per diluted share, for the third quarter of 2026, compared to $1.3 million, or $0.72 per diluted share, in the third quarter of 2025. For the first nine months of 2026, net income was $2.7 million, or $0.43 per diluted share, compared to $5.4 million, or $3.06 per diluted share, in the prior-year period.
• Adjusted EBITDA was $5.0 million for the third quarter of 2026, compared to $5.3 million in the prior-year period. For the first nine months of 2026, Adjusted EBITDA was $17.1 million, compared to $18.3 million in the prior-year period.
• Adjusted diluted earnings per share was $0.57 for the third quarter of 2026, compared to $1.19 in the prior-year period. For the first nine months of 2026, adjusted diluted earnings per share was $1.68, compared to $4.21 in the prior-year period.

Affiliated Practice Updates

• As of September 30, 2026, we supported 88 affiliated practices and 225 affiliated doctors.
• Third quarter patient retention rate was 90.2%.
• Patient visits increased to 180,955 across our affiliated dental practices.
• During the third quarter our affiliated dental practices completed one general practice acquisition in Arizona, as previously announced on September 23, 2026. The acquired practice’s impact on revenues and net earnings was not material for the quarter.
• As announced earlier this week, we completed the acquisition of Village Family DSO on November 6, 2026. The Village Family DSO is currently affiliated with Village Family Dental practices, a multi-specialty dental group based in Fayetteville, North Carolina. Integration activities commenced immediately following completion of the acquisition and Village Family financial performance will be included in our financial results beginning in the fourth quarter of 2026.

Balance Sheet, Liquidity, and Cash Flow

• Cash and cash equivalents were $23.2 million as of September 30, 2026.
• Total debt outstanding was approximately $10.6 million as of September 30, 2026, and our $15 million line of credit was undrawn at quarter end.
• Total shares outstanding were 5.1 million shares as of the end of the quarter.
• We generated $12.0 million in operating cash flow in the first nine months of 2026, a decrease of $4.8 million compared to the prior year that was driven by timing of working capital.
• Year-to-date capital investments were $7.6 million.

Full-Year 2026 Outlook

Following the completion of the Village Family DSO acquisition, we have incorporated the expected contribution from Village Family DSO for the remainder of 2026 into our full-year outlook. The outlook reflects Village Family DSO’s expected contribution from the closing date through year-end, as well as our current expectations for existing operations.

The updated outlook also reflects increased investment in clinical capacity, including the hiring and onboarding of additional hygienists during the second half of the year, as well as the impact of the cybersecurity event experienced during the third quarter. We believe the additional investments in clinical capacity position our affiliated practices to serve additional patient demand and support future growth.

	Year Ending		Year Ended		Percent
	December 31, 2026		December 31, 2025		Change
($ in millions)	(Outlook)		(Actual)		(At Midpoint)
Revenue	$262.0 – $265.0		$244.5		7.8%
Adjusted EBITDA	$21.2 – $22.2		$22.0		(1.4%)
Adjusted EBITDA margin	8.1% – 8.4%		9.0%

The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends, ongoing recruitment and retention initiatives, and contributions from recently affiliated practices. We continue to monitor patient demand, industry and professional staffing trends that could impact our outlook.

We expect to provide our full-year 2027 outlook in connection with the reporting of our fourth-quarter and full-year 2026 results.

Conference Call

As previously announced, the Company will host a conference call to discuss these results tomorrow morning, Friday, November 13, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call.

About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. As of September 30, 2026, the Company has supported 225 affiliated doctors across 88 practice locations in three states. The Company’s clinical support team consists of over 1,000 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into, and should not be considered a part of, this press release.

Basis of Consolidation

In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.

Forward Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as:

• Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations;
• Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors;
• Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;
• Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities;
• Competition for patients and clinicians in our markets and the impact on patient volumes and staffing;
• Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets in which we operate.

A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.

Non-GAAP Financial Measures

This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company.

Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results.

See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP.

Supplemental Financial Tables 

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in thousands, except share and per share amounts)
	For the Three Months Ended								For the Nine Months Ended
	September 30,								September 30,
	2026				2025				2026				2025
REVENUE	$	64,926			$	61,251			$	193,833			$	183,286
COST OF SERVICES
Salaries and benefits		41,896				37,785				125,905				110,518
Dental supplies and Laboratory fees		4,474				4,258				13,256				12,834
Office occupancy		4,393				4,043				13,053				12,133
Other practice expenses		3,998				3,726				11,668				10,741
Depreciation		1,983				2,002				5,874				5,861
TOTAL COST OF SERVICES		56,743				51,814				169,756				152,087
GROSS MARGIN		8,183				9,437				24,077				31,199
General and administrative expenses		7,863				7,265				23,539				21,573
Depreciation and amortization		434				389				1,276				1,141
OPERATING INCOME (LOSS)		(114	)			1,783				(738	)			8,485
INTEREST EXPENSE – NET		(89	)			(259	)			(347	)			(930	)
INCOME (LOSS) BEFORE TAXES		(203	)			1,524				(1,085	)			7,555
PROVISION/(BENEFIT) FOR INCOME TAXES		(1,905	)			274				(3,746	)			2,168
NET INCOME	$	1,702			$	1,251			$	2,661			$	5,387
EARNINGS PER SHARE:
Basic	$	0.35			$	0.72			$	0.58			$	3.06
Diluted	$	0.27			$	0.72			$	0.43			$	3.06
Basic weighted-average number of common shares outstanding		4,838,267				1,729,179				4,599,514				1,761,510
Diluted weighted-average number of common shares outstanding		6,360,881				1,729,179				6,179,442				1,761,510

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)
(in thousands)
	At September 30,			At December 31,
	2026			2025
ASSETS
Cash and cash equivalents	$	23,226		$	25,185
Accounts receivable – net of allowance		8,916			6,991
Other current assets		8,385			5,726
Total current assets		40,527			37,902
OTHER ASSETS:
Property and equipment and lease assets		75,521			73,828
Goodwill and Intangible assets, nets		32,527			28,360
Other assets		41,212			38,093
Total other assets		149,260			140,281
TOTAL ASSETS	$	189,787		$	178,183
LIABILITIES AND EQUITY
Accounts payable and other accrued liabilities	$	5,710		$	6,291
Payroll, benefits and short term deferred compensation		16,927			16,716
Current portion of debt and lease liabilities		8,945			8,606
Deferred Revenue and other current liabilities		5,276			4,120
Total current liabilities		36,858			35,733
LONG-TERM LIABILITIES:
Deferred compensation		68,147			68,417
Long-term debt and lease liabilities		50,078			51,744
Other long-term liabilities		607			486
Total long-term liabilities		118,832			120,647
TOTAL LIABILITIES	$	155,690		$	156,380
Total shareholders’ equity	$	34,097		$	21,803
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	189,787		$	178,183

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
	For the Nine Months Ended
	September 30,
	2026				2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	2,661			$	5,387
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		7,150				7,002
Deferred income taxes		(1,524	)			–
Change in cash surrender value of life insurance		(1,083	)			(1,589	)
Noncash lease and loss on disposal of equipment		46				24
Share based compensation		9,137				—
Interest received on notes to related parties		4				—
Changes in operating assets and liabilities		(4,425	)			5,961
Net cash flows from operating activities		11,966				16,785
NET CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchases of property and equipment	$	(7,571	)		$	(6,005	)
Life insurance premiums paid		(491	)			(1,287	)
Payments for purchases of dental practices		(4,090	)			(804	)
Loans to related parties evidenced by promissory notes		(600	)			—
Collection of notes to related parties		173				—
Net cash flows used in investing activities		(12,579	)			(8,096	)
CASH FLOWS USED IN FINANCING ACTIVITIES:
Dental practice purchase payments on deferred notes	$	(289	)		$	(568	)
Net change in checks issued in excess of cash balances		(96	)			(243	)
Net payments on debt and capital leases		(1,457	)			(1,470	)
Cash paid for share repurchase		—				(704	)
Issuance of common shares		496				—
Net cash flows used in financing activities		(1,346	)			(2,985	)
NET CHANGE IN CASH AND CASH EQUIVALENTS		(1,959	)			5,704
CASH AND CASH EQUIVALENTS – Beginning of period		25,185				2,672
CASH AND CASH EQUIVALENTS – End of period	$	23,226			$	8,376

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF GROSS MARGIN TO ADJUSTED GROSS MARGIN (unaudited)
(in thousands)
	For The Three Months Ended												For The Nine Months Ended
	September 30,												September 30,
	2026						2025						2026						2025
GROSS MARGIN	$	8,183		12.6	%		$	9,437		15.4	%		$	24,077		12.4	%		$	31,199		17.0	%
Addback:
Share based compensation		1,806		2.8	%			–		0.0	%			8,269		4.3	%			–		0.0	%
Restructuring(1)		32		0.0	%			–		0.0	%			69		0.0	%			109		0.1	%
Deferred compensation(2)		72		0.1	%			444		0.7	%			664		0.3	%			698		0.4	%
Depreciation		1,983		3.1	%			2,002		3.3	%			5,874		3.0	%			5,861		3.2	%
ADJUSTED GROSS MARGIN	$	12,076					$	11,883					$	38,953					$	37,867
ADJUSTED GROSS MARGIN PERCENTAGE				18.6	%					19.4	%					20.1	%					20.7	%
(1) Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(2) Deferred compensation costs primarily consist of expenses incurred with the Company’s active and inactive deferred compensation arrangements.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (unaudited)
(in thousands)
	For the Three Months Ended													For the Nine Months Ended
	September 30,													September 30,
	2026							2025						2026							2025
NET INCOME	$	1,702			2.6	%		$	1,251		2.0	%		$	2,661			1.4	%		$	5,387		2.9	%
Addback:
Provision/(Benefit) for income tax		(1,905	)		(2.9	%)			274		0.4	%			(3,746	)		(1.9	%)			2,168		1.2	%
Interest expense, net		89			0.1	%			259		0.4	%			347			0.2	%			930		0.5	%
Depreciation and amortization		2,417			3.7	%			2,391		3.9	%			7,150			3.7	%			7,002		3.8	%
EBITDA	$	2,303			3.5	%		$	4,175		6.8	%		$	6,412			3.3	%		$	15,487		8.4	%
Adjustments:
Share based compensation		2,078			3.2	%			–		0.0	%			9,137			4.7	%			–		0.0	%
Acquisition and integration costs(1) (5)		484			0.7	%			–		0.0	%			831			0.4	%			–		0.0	%
Initial public offering costs(2) (5)		–			0.0	%			680		1.1	%			21			0.0	%			1,947		1.1	%
Restructuring(3) (5)		32			0.0	%			–		0.0	%			69			0.0	%			184		0.1	%
Deferred compensation(4)		72			0.1	%			444		0.7	%			664			0.3	%			698		0.4	%
ADJUSTED EBITDA	$	4,969						$	5,299					$	17,134						$	18,316
ADJUSTED EBITDA PERCENTAGE					7.7	%					8.7	%						8.8	%					10.0	%
(1) Acquisition and integration costs primarily consist of expenses related to acquisition related legal costs and integration related costs.
(2) Initial public offering costs primarily consist of expenses incurred in connection with the Company’s initial public offering.
(3) Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(4) Deferred compensation costs primarily consist of expenses incurred with the Company’s active and inactive deferred compensation arrangements.
(5) Prior-period amounts have been recast to conform to the current-period presentation. The recast reflects the reclassification of amounts previously reported as restructuring costs into initial public offering costs, acquisition and integration costs, and restructuring costs and had no impact on total non-GAAP adjustments.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE (unaudited)
(in thousands, except share and per share amounts)
	For the Three Months Ended								For the Nine Months Ended
	September 30,								September 30,
	2026				2025				2026				2025
EARNINGS ATTRIBUTABLE TO COMMON STOCKHOLDERS:	$	1,702			$	1,251			$	2,661			$	5,387
Adjustments:
Share based compensation		2,078				–				9,137				–
Acquisition and integration costs(1) (6)		484				–				831				–
Initial public offering costs(2) (6)		–				680				21				1,947
Restructuring(3) (6)		32				–				69				184
Deferred compensation(4)		72				444				664				698
Income tax effect of the Adjustments(5)		(746	)			(315	)			(3,002	)			(792	)
ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS	$	3,622			$	2,060			$	10,381			$	7,424
Adjusted Weighted Average Diluted Shares – Reconciliation
WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET LOSS PER SHARE, DILUTED		6,360,881				1,729,179				6,179,442				1,761,510
ADJUSTED WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED		6,360,881				1,729,179				6,179,442				1,761,510
ADJUSTED DILUTED EARNINGS PER SHARE:	$	0.57			$	1.19			$	1.68			$	4.21
(1) Acquisition and integration costs primarily consist of expenses related to acquisition related legal costs and integration related costs.
(2) Initial public offering costs primarily consist of expenses incurred in connection with the Company’s initial public offering.
(3) Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(4) Deferred compensation costs primarily consist of expenses incurred with the Company’s active and inactive deferred compensation arrangements.
(5) Income tax effect is based on an estimated long-term annual effective tax rate of 28% tax rate for the three and nine months ended September 30, 2026 and September 30, 2025. The Company’s estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used in order to provide consistency across periods.
(6) Prior-period amounts have been recast to conform to the current-period presentation. The recast reflects the reclassification of amounts previously reported as restructuring costs into initial public offering costs, acquisition and integration costs, and restructuring costs and had no impact on total non-GAAP adjustments.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONSOLIDATED OPERATING METRICS (unaudited)
	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2026			2025			2026			2025
Patient Visits(1)	180,955			179,111			545,051			540,240
Same Practice Revenue Growth(2)	3.2	%		9.9	%		3.0	%		5.8	%
Patient Retention Rate(3)	90.2	%		89.8	%		90.2	%		89.8	%
Doctor Count(4)	225			218
(1) A patient visit is counted when service is provided to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies. Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients to complete their diagnosed dental treatment plans.
(2) Same practice revenues represent total revenues for same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition, visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the level of patient service provided inside and outside of the dental practices.
(3) Patient retention rate is calculated by counting patients that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate levels of staffing, recruiting, advertising and facility expansion opportunities.
(4) Dentists operating in one of our affiliated dental practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over- quarter change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making relating to matters such as appropriate staffing levels and recruiting needs.

CONTACT: Company Contact Information

Investor Contact:
Park Dental Partners Investor Relations Team
763-233-3377
ir@parkdentalpartners.com

Media Contact:
Park Dental Partners Media Relations Team
651-633-0500
marketing@parkdentalpartners.com

This press release corrects the “Percent Change (At Midpoint)” in the outlook table contained in the Company’s press release originally issued on November 12, 2026.  The corrected table is included herein.  There were no changes to the outlook ranges. In all other respects, the press release remains unchanged.

MINNEAPOLIS, Nov. 13, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its third quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited, in millions, except per share data, and Doctor counts)
	Three Months Ended September 30,													Nine Months Ended September 30,
	2026			2025							Change			2026					2025				Change
Revenue	$64.9			$61.3							6.0	%		$193.8					$183.3				5.8	%
Gross Margin	$8.2			$9.4							(13.3	%)		$24.1					$31.2				(22.8	%)
Gross Margin percentage	12.6	%		15.4					%		(280 bps)			12.4			%		17.0		%		(460 bps)
Net Income	$1.7			$1.3							36.1	%		$2.7					$5.4				(50.6	%)
Diluted EPS	$0.27			$0.72							($0.45	)		$0.43					$3.06				($2.63	)
Adjusted Gross Margin(a)	$12.1			$11.9							1.6	%		$39.0					$37.9				2.9	%
Adjusted Gross Margin Percentage(a)	18.6	%		19.4					%		(80 bps)			20.1			%		20.7		%		(60 bps)
Adjusted EBITDA(b)	$5.0			$5.3							(6.2	%)		$17.1					$18.3				(6.5	%)
Adjusted EBITDA margin(b)	7.7	%		8.7					%		(100 bps)			8.8			%		10.0		%		(120 bps)
Adjusted Diluted EPS(c)	$0.57			$ 1.19							($0.62	)		$1.68					$4.21				($2.53	)
Same Practice Revenue Growth	3.2	%		9.9					%		(670 bps	)		3.0			%		5.8		%		(280 bps)
Practicing Affiliated Doctors	225			218							3.2	%

^{(a) See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below
(b) See Non GAAP Reconciliation of Net Income to Adjusted EBITDA below
(c) See Non GAAP Reconciliation of Earnings Per Share to Adjusted Earnings Per Share below}

Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors

“Third-quarter revenue increased 6%, supported by same-practice growth, an expanding affiliated doctor base and contributions from recently acquired practices. We have made meaningful progress adding clinical capacity and strengthening our platform, and our focus now is converting that capacity and revenue growth into improved productivity and stronger earnings performance.

The completion of the Village Family transaction represents an important step in our growth strategy and extends our affiliated practice network into a fourth state. We remain focused on disciplined integration, supporting our affiliated practices and executing against the opportunities already within our business.”

Financial Results

• Revenue increased 6.0% to $64.9 million for the third quarter of 2026, compared to $61.3 million in the prior-year period. For the first nine months of 2026, revenue increased 5.8% to $193.8 million, compared to $183.3 million in the prior-year period. The increases were primarily driven by reimbursement trends, acquisitions completed since the comparable prior-year periods, and growth in clinical hours. Revenue from acquisitions in the past 12 months contributed approximately $1.2 million in the quarter and $3.7 million year-to-date.
• Gross margin was $8.2 million for the third quarter of 2026, compared to $9.4 million in the prior-year period. For the first nine months of 2026, gross profit was $24.1 million, compared to $31.2 million in the prior-year period. Gross profit was impacted by higher salaries and benefits expense, including doctor share-based compensation associated with the Company’s public company transition.
• Net income was $1.7 million, or $0.27 per diluted share, for the third quarter of 2026, compared to $1.3 million, or $0.72 per diluted share, in the third quarter of 2025. For the first nine months of 2026, net income was $2.7 million, or $0.43 per diluted share, compared to $5.4 million, or $3.06 per diluted share, in the prior-year period.
• Adjusted EBITDA was $5.0 million for the third quarter of 2026, compared to $5.3 million in the prior-year period. For the first nine months of 2026, Adjusted EBITDA was $17.1 million, compared to $18.3 million in the prior-year period.
• Adjusted diluted earnings per share was $0.57 for the third quarter of 2026, compared to $1.19 in the prior-year period. For the first nine months of 2026, adjusted diluted earnings per share was $1.68, compared to $4.21 in the prior-year period.

Affiliated Practice Updates

• As of September 30, 2026, we supported 88 affiliated practices and 225 affiliated doctors.
• Third quarter patient retention rate was 90.2%.
• Patient visits increased to 180,955 across our affiliated dental practices.
• During the third quarter our affiliated dental practices completed one general practice acquisition in Arizona, as previously announced on September 23, 2026. The acquired practice’s impact on revenues and net earnings was not material for the quarter.
• As announced earlier this week, we completed the acquisition of Village Family DSO on November 6, 2026. The Village Family DSO is currently affiliated with Village Family Dental practices, a multi-specialty dental group based in Fayetteville, North Carolina. Integration activities commenced immediately following completion of the acquisition and Village Family financial performance will be included in our financial results beginning in the fourth quarter of 2026.

Balance Sheet, Liquidity, and Cash Flow

• Cash and cash equivalents were $23.2 million as of September 30, 2026.
• Total debt outstanding was approximately $10.6 million as of September 30, 2026, and our $15 million line of credit was undrawn at quarter end.
• Total shares outstanding were 5.1 million shares as of the end of the quarter.
• We generated $12.0 million in operating cash flow in the first nine months of 2026, a decrease of $4.8 million compared to the prior year that was driven by timing of working capital.
• Year-to-date capital investments were $7.6 million.

Full-Year 2026 Outlook

Following the completion of the Village Family DSO acquisition, we have incorporated the expected contribution from Village Family DSO for the remainder of 2026 into our full-year outlook. The outlook reflects Village Family DSO’s expected contribution from the closing date through year-end, as well as our current expectations for existing operations.

The updated outlook also reflects increased investment in clinical capacity, including the hiring and onboarding of additional hygienists during the second half of the year, as well as the impact of the cybersecurity event experienced during the third quarter. We believe the additional investments in clinical capacity position our affiliated practices to serve additional patient demand and support future growth.

	Year Ending		Year Ended		Percent
	December 31, 2026		December 31, 2025		Change
($ in millions)	(Outlook)		(Actual)		(At Midpoint)
Revenue	$262.0 – $265.0		$244.5		7.8%
Adjusted EBITDA	$21.2 – $22.2		$22.0		(1.4%)
Adjusted EBITDA margin	8.1% – 8.4%		9.0%

The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends, ongoing recruitment and retention initiatives, and contributions from recently affiliated practices. We continue to monitor patient demand, industry and professional staffing trends that could impact our outlook.

We expect to provide our full-year 2027 outlook in connection with the reporting of our fourth-quarter and full-year 2026 results.

Conference Call

As previously announced, the Company will host a conference call to discuss these results tomorrow morning, Friday, November 13, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call.

About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. As of September 30, 2026, the Company has supported 225 affiliated doctors across 88 practice locations in three states. The Company’s clinical support team consists of over 1,000 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into, and should not be considered a part of, this press release.

Basis of Consolidation

In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.

Forward Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as:

• Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations;
• Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors;
• Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;
• Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities;
• Competition for patients and clinicians in our markets and the impact on patient volumes and staffing;
• Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets in which we operate.

A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.

Non-GAAP Financial Measures

This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company.

Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results.

See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP.

Supplemental Financial Tables 

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in thousands, except share and per share amounts)
	For the Three Months Ended								For the Nine Months Ended
	September 30,								September 30,
	2026				2025				2026				2025
REVENUE	$	64,926			$	61,251			$	193,833			$	183,286
COST OF SERVICES
Salaries and benefits		41,896				37,785				125,905				110,518
Dental supplies and Laboratory fees		4,474				4,258				13,256				12,834
Office occupancy		4,393				4,043				13,053				12,133
Other practice expenses		3,998				3,726				11,668				10,741
Depreciation		1,983				2,002				5,874				5,861
TOTAL COST OF SERVICES		56,743				51,814				169,756				152,087
GROSS MARGIN		8,183				9,437				24,077				31,199
General and administrative expenses		7,863				7,265				23,539				21,573
Depreciation and amortization		434				389				1,276				1,141
OPERATING INCOME (LOSS)		(114	)			1,783				(738	)			8,485
INTEREST EXPENSE – NET		(89	)			(259	)			(347	)			(930	)
INCOME (LOSS) BEFORE TAXES		(203	)			1,524				(1,085	)			7,555
PROVISION/(BENEFIT) FOR INCOME TAXES		(1,905	)			274				(3,746	)			2,168
NET INCOME	$	1,702			$	1,251			$	2,661			$	5,387
EARNINGS PER SHARE:
Basic	$	0.35			$	0.72			$	0.58			$	3.06
Diluted	$	0.27			$	0.72			$	0.43			$	3.06
Basic weighted-average number of common shares outstanding		4,838,267				1,729,179				4,599,514				1,761,510
Diluted weighted-average number of common shares outstanding		6,360,881				1,729,179				6,179,442				1,761,510

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)
(in thousands)
	At September 30,			At December 31,
	2026			2025
ASSETS
Cash and cash equivalents	$	23,226		$	25,185
Accounts receivable – net of allowance		8,916			6,991
Other current assets		8,385			5,726
Total current assets		40,527			37,902
OTHER ASSETS:
Property and equipment and lease assets		75,521			73,828
Goodwill and Intangible assets, nets		32,527			28,360
Other assets		41,212			38,093
Total other assets		149,260			140,281
TOTAL ASSETS	$	189,787		$	178,183
LIABILITIES AND EQUITY
Accounts payable and other accrued liabilities	$	5,710		$	6,291
Payroll, benefits and short term deferred compensation		16,927			16,716
Current portion of debt and lease liabilities		8,945			8,606
Deferred Revenue and other current liabilities		5,276			4,120
Total current liabilities		36,858			35,733
LONG-TERM LIABILITIES:
Deferred compensation		68,147			68,417
Long-term debt and lease liabilities		50,078			51,744
Other long-term liabilities		607			486
Total long-term liabilities		118,832			120,647
TOTAL LIABILITIES	$	155,690		$	156,380
Total shareholders’ equity	$	34,097		$	21,803
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	189,787		$	178,183

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
	For the Nine Months Ended
	September 30,
	2026				2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	2,661			$	5,387
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		7,150				7,002
Deferred income taxes		(1,524	)			–
Change in cash surrender value of life insurance		(1,083	)			(1,589	)
Noncash lease and loss on disposal of equipment		46				24
Share based compensation		9,137				—
Interest received on notes to related parties		4				—
Changes in operating assets and liabilities		(4,425	)			5,961
Net cash flows from operating activities		11,966				16,785
NET CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchases of property and equipment	$	(7,571	)		$	(6,005	)
Life insurance premiums paid		(491	)			(1,287	)
Payments for purchases of dental practices		(4,090	)			(804	)
Loans to related parties evidenced by promissory notes		(600	)			—
Collection of notes to related parties		173				—
Net cash flows used in investing activities		(12,579	)			(8,096	)
CASH FLOWS USED IN FINANCING ACTIVITIES:
Dental practice purchase payments on deferred notes	$	(289	)		$	(568	)
Net change in checks issued in excess of cash balances		(96	)			(243	)
Net payments on debt and capital leases		(1,457	)			(1,470	)
Cash paid for share repurchase		—				(704	)
Issuance of common shares		496				—
Net cash flows used in financing activities		(1,346	)			(2,985	)
NET CHANGE IN CASH AND CASH EQUIVALENTS		(1,959	)			5,704
CASH AND CASH EQUIVALENTS – Beginning of period		25,185				2,672
CASH AND CASH EQUIVALENTS – End of period	$	23,226			$	8,376

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF GROSS MARGIN TO ADJUSTED GROSS MARGIN (unaudited)
(in thousands)
	For The Three Months Ended												For The Nine Months Ended
	September 30,												September 30,
	2026						2025						2026						2025
GROSS MARGIN	$	8,183		12.6	%		$	9,437		15.4	%		$	24,077		12.4	%		$	31,199		17.0	%
Addback:
Share based compensation		1,806		2.8	%			–		0.0	%			8,269		4.3	%			–		0.0	%
Restructuring(1)		32		0.0	%			–		0.0	%			69		0.0	%			109		0.1	%
Deferred compensation(2)		72		0.1	%			444		0.7	%			664		0.3	%			698		0.4	%
Depreciation		1,983		3.1	%			2,002		3.3	%			5,874		3.0	%			5,861		3.2	%
ADJUSTED GROSS MARGIN	$	12,076					$	11,883					$	38,953					$	37,867
ADJUSTED GROSS MARGIN PERCENTAGE				18.6	%					19.4	%					20.1	%					20.7	%
(1) Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(2) Deferred compensation costs primarily consist of expenses incurred with the Company’s active and inactive deferred compensation arrangements.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (unaudited)
(in thousands)
	For the Three Months Ended													For the Nine Months Ended
	September 30,													September 30,
	2026							2025						2026							2025
NET INCOME	$	1,702			2.6	%		$	1,251		2.0	%		$	2,661			1.4	%		$	5,387		2.9	%
Addback:
Provision/(Benefit) for income tax		(1,905	)		(2.9	%)			274		0.4	%			(3,746	)		(1.9	%)			2,168		1.2	%
Interest expense, net		89			0.1	%			259		0.4	%			347			0.2	%			930		0.5	%
Depreciation and amortization		2,417			3.7	%			2,391		3.9	%			7,150			3.7	%			7,002		3.8	%
EBITDA	$	2,303			3.5	%		$	4,175		6.8	%		$	6,412			3.3	%		$	15,487		8.4	%
Adjustments:
Share based compensation		2,078			3.2	%			–		0.0	%			9,137			4.7	%			–		0.0	%
Acquisition and integration costs(1) (5)		484			0.7	%			–		0.0	%			831			0.4	%			–		0.0	%
Initial public offering costs(2) (5)		–			0.0	%			680		1.1	%			21			0.0	%			1,947		1.1	%
Restructuring(3) (5)		32			0.0	%			–		0.0	%			69			0.0	%			184		0.1	%
Deferred compensation(4)		72			0.1	%			444		0.7	%			664			0.3	%			698		0.4	%
ADJUSTED EBITDA	$	4,969						$	5,299					$	17,134						$	18,316
ADJUSTED EBITDA PERCENTAGE					7.7	%					8.7	%						8.8	%					10.0	%
(1) Acquisition and integration costs primarily consist of expenses related to acquisition related legal costs and integration related costs.
(2) Initial public offering costs primarily consist of expenses incurred in connection with the Company’s initial public offering.
(3) Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(4) Deferred compensation costs primarily consist of expenses incurred with the Company’s active and inactive deferred compensation arrangements.
(5) Prior-period amounts have been recast to conform to the current-period presentation. The recast reflects the reclassification of amounts previously reported as restructuring costs into initial public offering costs, acquisition and integration costs, and restructuring costs and had no impact on total non-GAAP adjustments.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE (unaudited)
(in thousands, except share and per share amounts)
	For the Three Months Ended								For the Nine Months Ended
	September 30,								September 30,
	2026				2025				2026				2025
EARNINGS ATTRIBUTABLE TO COMMON STOCKHOLDERS:	$	1,702			$	1,251			$	2,661			$	5,387
Adjustments:
Share based compensation		2,078				–				9,137				–
Acquisition and integration costs(1) (6)		484				–				831				–
Initial public offering costs(2) (6)		–				680				21				1,947
Restructuring(3) (6)		32				–				69				184
Deferred compensation(4)		72				444				664				698
Income tax effect of the Adjustments(5)		(746	)			(315	)			(3,002	)			(792	)
ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS	$	3,622			$	2,060			$	10,381			$	7,424
Adjusted Weighted Average Diluted Shares – Reconciliation
WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET LOSS PER SHARE, DILUTED		6,360,881				1,729,179				6,179,442				1,761,510
ADJUSTED WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED		6,360,881				1,729,179				6,179,442				1,761,510
ADJUSTED DILUTED EARNINGS PER SHARE:	$	0.57			$	1.19			$	1.68			$	4.21
(1) Acquisition and integration costs primarily consist of expenses related to acquisition related legal costs and integration related costs.
(2) Initial public offering costs primarily consist of expenses incurred in connection with the Company’s initial public offering.
(3) Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(4) Deferred compensation costs primarily consist of expenses incurred with the Company’s active and inactive deferred compensation arrangements.
(5) Income tax effect is based on an estimated long-term annual effective tax rate of 28% tax rate for the three and nine months ended September 30, 2026 and September 30, 2025. The Company’s estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used in order to provide consistency across periods.
(6) Prior-period amounts have been recast to conform to the current-period presentation. The recast reflects the reclassification of amounts previously reported as restructuring costs into initial public offering costs, acquisition and integration costs, and restructuring costs and had no impact on total non-GAAP adjustments.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONSOLIDATED OPERATING METRICS (unaudited)
	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2026			2025			2026			2025
Patient Visits(1)	180,955			179,111			545,051			540,240
Same Practice Revenue Growth(2)	3.2	%		9.9	%		3.0	%		5.8	%
Patient Retention Rate(3)	90.2	%		89.8	%		90.2	%		89.8	%
Doctor Count(4)	225			218
(1) A patient visit is counted when service is provided to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies. Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients to complete their diagnosed dental treatment plans.
(2) Same practice revenues represent total revenues for same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition, visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the level of patient service provided inside and outside of the dental practices.
(3) Patient retention rate is calculated by counting patients that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate levels of staffing, recruiting, advertising and facility expansion opportunities.
(4) Dentists operating in one of our affiliated dental practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over- quarter change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making relating to matters such as appropriate staffing levels and recruiting needs.

CONTACT: Company Contact Information

Investor Contact:
Park Dental Partners Investor Relations Team
763-233-3377
ir@parkdentalpartners.com

Media Contact:
Park Dental Partners Media Relations Team
651-633-0500
marketing@parkdentalpartners.com

THOMASVILLE, Ga., Nov. 13, 2026 (GLOBE NEWSWIRE) — Thomasville Bancshares, Inc. (OTCID:THVB), the parent company of Thomasville National Bank and TNB Financial Services, announced that its Board of Directors has declared a cash dividend of $1.75 per share. The cash dividend will be paid on December 15, 2026, to shareholders of record as of December 2, 2026. The total dividend paid for the year of $3.25 represents a 20% increase over the 2025 dividend paid of $2.70.

In announcing the dividend, the Company’s Chairman and CEO Stephen H. Cheney stated that “We are pleased that our Bank’s strong financial performance allows us to continue our tradition of paying a dividend in December to our shareholders.”

Cheney also stated “Over the last 31 years we recognize the support of this community, our shareholders and customers have made our Bank extremely successful. We are very pleased to share the earnings of the Company with the people that made it a reality. One of the most important benefits of a locally owned bank is that the earnings remain in the community.” Over the past twenty-seven years, TNB has returned over $144 million in dividends to local shareholders.

About Thomasville Bancshares, Inc., and Thomasville National Bank

Thomasville Bancshares, Inc. was founded in 1995 as the holding company for Thomasville National Bank. TNB along with its two banking divisions; St. Simons Bank & Trust and Tallahassee National Bank, have total assets over $2.2 billion providing full-service banking and commercial lending across the South Georgia and North Florida region. TNB is consistently recognized as a top performing community bank. In 2026, TNB was ranked 7^th nationally in American Banker’s Top Performing Banks $2B to $10B in Assets based upon three-year average return on shareholders’ equity. The Bank’s trust and investment division, TNB Financial Services, has client assets over $6 billion under advisement and provides financial planning, investments, trust, brokerage, and other related financial services. TNBFS has offices located in Georgia, Florida, South Carolina, Illinois, and Ohio. The Company is headquartered in Thomasville, Georgia and has over 800 local shareholders. Thomasville National Bank is Member FDIC and an Equal Housing Lender. For more information, call 229-226-3300 or visit www.tnbank.com.

THOMASVILLE, Ga., Nov. 13, 2026 (GLOBE NEWSWIRE) — Thomasville Bancshares, Inc. (OTCID:THVB), the parent company of Thomasville National Bank and TNB Financial Services, announced that its Board of Directors has declared a cash dividend of $1.75 per share. The cash dividend will be paid on December 15, 2026, to shareholders of record as of December 2, 2026. The total dividend paid for the year of $3.25 represents a 20% increase over the 2025 dividend paid of $2.70.

In announcing the dividend, the Company’s Chairman and CEO Stephen H. Cheney stated that “We are pleased that our Bank’s strong financial performance allows us to continue our tradition of paying a dividend in December to our shareholders.”

Cheney also stated “Over the last 31 years we recognize the support of this community, our shareholders and customers have made our Bank extremely successful. We are very pleased to share the earnings of the Company with the people that made it a reality. One of the most important benefits of a locally owned bank is that the earnings remain in the community.” Over the past twenty-seven years, TNB has returned over $144 million in dividends to local shareholders.

About Thomasville Bancshares, Inc., and Thomasville National Bank

Thomasville Bancshares, Inc. was founded in 1995 as the holding company for Thomasville National Bank. TNB along with its two banking divisions; St. Simons Bank & Trust and Tallahassee National Bank, have total assets over $2.2 billion providing full-service banking and commercial lending across the South Georgia and North Florida region. TNB is consistently recognized as a top performing community bank. In 2026, TNB was ranked 7^th nationally in American Banker’s Top Performing Banks $2B to $10B in Assets based upon three-year average return on shareholders’ equity. The Bank’s trust and investment division, TNB Financial Services, has client assets over $6 billion under advisement and provides financial planning, investments, trust, brokerage, and other related financial services. TNBFS has offices located in Georgia, Florida, South Carolina, Illinois, and Ohio. The Company is headquartered in Thomasville, Georgia and has over 800 local shareholders. Thomasville National Bank is Member FDIC and an Equal Housing Lender. For more information, call 229-226-3300 or visit www.tnbank.com.